Genus PLC
LSE:GNS
Genus PLC
LSE:GNS
Price:
1 820 GBX
3.76%
Market Closed
Updated:
May 30, 2024
Genus PLC
Cash from Investing Activities
|
Genus PLC
Cash from Investing Activities Peer Comparison
Comparables:
CNTA
EXAI
AUTL
BCYC
IMCR
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Genus PLC
LSE:GNS
|
Cash from Investing Activities
-£21.4m
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
6%
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Cash from Investing Activities
-$127m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Exscientia PLC
NASDAQ:EXAI
|
Cash from Investing Activities
-£21.5m
|
CAGR 3-Years
-65%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Cash from Investing Activities
-$11m
|
CAGR 3-Years
9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Cash from Investing Activities
-$841k
|
CAGR 3-Years
18%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Cash from Investing Activities
-£5.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Genus PLC's Cash from Investing Activities?
Cash from Investing Activities
-21.4m
GBP
-21.4m
GBP
Based on the financial report for Dec 31, 2023, Genus PLC's Cash from Investing Activities amounts to -21.4m GBP.
What is Genus PLC's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
6%
6%
Over the last year, the Cash from Investing Activities growth was 62%. The average annual Cash from Investing Activities growth rates for Genus PLC have been 11% over the past three years , 15% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
